Compare · EUDA vs HIMS
EUDA vs HIMS
Side-by-side comparison of EUDA Health Holdings Limited (EUDA) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EUDA and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $7.86B, about 172.5x EUDA ($45.5M).
- Over the past year, EUDA is down 79.4% and HIMS is down 26.8% - HIMS leads by 52.5 points.
- HIMS has been more active in the news (28 items in the past 4 weeks vs 7 for EUDA).
- HIMS has more recent analyst coverage (25 ratings vs 0 for EUDA).
- Company
- EUDA Health Holdings Limited
- Hims & Hers Health Inc.
- Price
- $15.02-16.60%
- $33.87+3.55%
- Market cap
- $45.5M
- $7.86B
- 1M return
- -16.09%
- +34.48%
- 1Y return
- -79.37%
- -26.85%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2019
- News (4w)
- 7
- 28
- Recent ratings
- 0
- 25
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest EUDA
- SEC Form 424B5 filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- Amendment: SEC Form SCHEDULE 13G/A filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
- EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
- SEC Form F-3 filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- SEC Form 20-F filed by EUDA Health Holdings Limited
Latest HIMS
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)
- Chief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)
- Chief Policy Officer Autor Deborah M. covered exercise/tax liability with 15,396 shares and converted options into 32,919 shares, increasing direct ownership by 56% to 48,961 units (SEC Form 4)
- PAO Becklund Irene converted options into 15,971 shares, covered exercise/tax liability with 5,870 shares and sold $370,518 worth of shares (12,063 units at $30.72) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 6,790 units (SEC Form 4) (for tax liability)
- Chief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 23,315 shares, increasing direct ownership by 6% to 318,314 units (SEC Form 4) to cover taxes
- Chief Executive Officer Dudum Andrew covered exercise/tax liability with 85,632 shares and converted options into 154,991 shares, increasing direct ownership by 8% to 957,043 units (SEC Form 4) (withholding tax)
- CTO Elshenawy Mohamed converted options into 282,597 shares, covered exercise/tax liability with 151,534 shares and sold $946,260 worth of shares (30,040 units at $31.50) as part of a pre-agreed trading plan (SEC Form 4) (tax withholding)